Zim Laboratories Share Price

CMP as on14-Jun-21 11:44

₹ 94.10
0.45 0.48%

Open

₹ 94.60

Turnover (lac)

₹ 2

Prev. Close

₹ 93.65

Day's Vol (shares)

₹ 9,395

Day's Range

₹ 94.00
₹ 100.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 21-May-2021 - -
Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2021 ,inter alia, to consider and approve a) the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2021. b) the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2021 (prepared pursuant to SEBI (LODR) Regulations, 2015). This is to inform you that the Board of Directors in their meeting held today has inter-alia considered and approved: 1) the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2021. 2) the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2021 (prepared pursuant to SEBI (LODR) Regulations, 2015). Walker Chandiok & Co LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditors report with an unmodified opinion on the financial results for the year ended 31.03.2021 which is enclosed herewith. The Board Meeting commenced at 11:45 a.m. and concluded at 01:30 p.m. (As Per BSE Announcement Dated 29.05.2021)
Board Meeting - 05-Feb-2021 - -
Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine month ended 31st December, 2020. This is to inform you that the Board of Directors at its meeting held today have inter-alia considered and approved Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended 31.12.2020. Copy of Financial Results (Consolidated and Standalone) along with Limited Review Report issued by Walker Chandiok & Co LLP, Statutory Auditor of the Company is enclosed. The Board Meeting commenced at 12.00 noon and concluded at 02.00 p.m. (As per BSE Announcement Dated on 11/2/2021)
Board Meeting - 20-Oct-2020 - -
Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2020 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2020. This is to inform you that the Board of Directors at its meeting held today have inter-alia considered and approved Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended 30.09.2020. Copy of Financial Results (Consolidated and Standalone) along with Limited Review Report issued by Walker Chandiok & Co LLP, Statutory Auditor of the Company is enclosed. (As per BSE Announcement Dated on 26/10/2020)
Board Meeting - 28-Jul-2020 - -
Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2020 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2020 This is to inform you that the Board of Directors in their meeting held today has inter-alia considered and approved: 1)Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2020. 2)Reappointment of Walker Chandiok and Co. LLP, as Statutory Auditor for the term of five years commencing from F.Y. 2020-21 subject to the approval of Shareholders of the Company in the Annual General Meeting. The Board Meeting commenced at 03.00 p.m. and concluded at 05.30 p.m. (As Per BSE Announcement Dated on 04/08/2020)
Open ZERO Brokerage Demat Account